Valiant Laboratories Limited (VALIANTLAB.BO)
BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹124.20 (-1.97%) as of
Key statistics
- Market cap
- 6.75B
- P/E (TTM)
- 44.20
- EPS (TTM)
- 2.81
- Dividend yield
- 0.00%
- 52-week range
- 50.00 – 141.30
- Beta
- 0.92
- Revenue (TTM)
- 3.06B
- Profit margin
- 5.23%
- Volume
- 1.00k
About Valiant Laboratories Limited
Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopoeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also manufactures and sells specialty chemicals and chemical intermediates, including chlorophenol derivatives, benzene-based specialty chemicals and other chemical intermediates to agrochemicals, pharmaceuticals, dyes and pigments, polymers, personal care, and allied industries. The company was formerly known as Bharat Chemicals and changed its name to Valiant Laboratories Limited in August 2021. The company was founded in 1980 and is based in Mumbai, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Mumbai, India
- Employees
- 84
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.